JPMorgan Reiterates Outperform on iRhythm Technologies (IRTC) Ahead of ACC Medical Meeting
Tweet Send to a Friend
JPMorgan analyst, Robbie Marcus, reiterated an Overweight rating and $110.00 price target on iRhythm Technologies (NASDAQ: IRTC) ahead of the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
